Mounjaro®
Starting from £179.99/mo
Start journey Learn moreSulphurous, egg-smelling burps are one of the more unpleasant surprises people report on semaglutide, and they tend to appear sooner than patients expect. The burping itself is a recognised side effect of GLP-1 medicines like Wegovy, documented in clinical data and explained by a clear physiological mechanism. This page covers why it happens, what the evidence shows, and the practical steps most people find useful, so you can make an informed decision about what to do next.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
When burps smell strongly of sulphur or rotten eggs, the natural instinct is to check the pen, check the food, or assume something has gone wrong. That instinct is understandable. It is also, in this case, almost always incorrect.
Semaglutide works in part by slowing how quickly food moves out of the stomach, a process called delayed gastric emptying. This is deliberate: the slower transit contributes to the feeling of fullness that helps reduce how much people eat. The side effect of that slower transit, particularly in the first weeks of treatment, is that food spends longer in the stomach fermenting. Proteins are rich in sulphur-containing amino acids. When they ferment, hydrogen sulphide gas is produced. That gas has to go somewhere, and it comes up as burps.
The result smells unpleasant. It is not dangerous in itself, and it is not a sign the pen is faulty or the medicine is not working. Burping and other gastrointestinal effects are listed in the prescribing information for semaglutide precisely because they are a predictable consequence of how the medicine works. The NHS semaglutide medicines page notes digestive side effects as common, particularly early in treatment and after each dose step up.
What the smell is telling you is that gastric emptying has slowed, which is the medicine doing its job. The intensity usually decreases as your body adapts.
Timing matters here. Most people who experience sulphurous burping notice it most in two distinct windows: in the first two to four weeks after their starting dose, and then again briefly after each dose increase. Both follow the same pattern for the same reason. Each upward step in the titration schedule increases the degree of gastric slowing, and the digestive system needs time to recalibrate.
The effect is also strongly influenced by what you eat. High-protein meals produce more sulphurous gas regardless of medication, because the amino acids involved (cysteine and methionine, found in eggs, meat, dairy and legumes) are the raw material for hydrogen sulphide. On semaglutide, those foods sit in the stomach longer, which amplifies the fermentation. Some people notice a particular link between egg-burps on semaglutide and eating eggs, red meat or high-protein shakes in the evening, when digestion is naturally slower.
Carbonated drinks compound the problem by adding gas directly. Large meals do the same by stretching the stomach and extending the time food takes to move through. Eating quickly, which leads to swallowed air, is a smaller but real contributor.
A practical check worth doing before your next meal: look at the last time you ate heavily, whether it was protein-rich, and whether you had anything fizzy in the same sitting. Most people can trace a pattern within a few days, and that pattern points directly at what to adjust first.
No clinical trial has been designed specifically around semaglutide-related sulphurous burping, so the guidance here is drawn from what is known about delayed gastric emptying and from the general evidence base for managing GI side effects with GLP-1 medicines.
Smaller, more frequent meals reduce the volume of food sitting in the stomach at any one time. Slowing down while eating reduces swallowed air. Sitting upright for at least thirty minutes after a meal and avoiding lying down straight after eating gives gravity a chance to assist digestion. Reducing the volume of high-sulphur protein foods at a single sitting, rather than cutting them out, is usually sufficient. If you want to read more about the wider picture of burping while on semaglutide, there is a dedicated page covering the full scope of that symptom.
The other lever is dose timing. Most people inject Wegovy once a week, and for some the day or two following the injection brings a noticeable uptick in GI symptoms. Experimenting with the day of the week, or avoiding a heavy protein meal on injection day, can make a practical difference.
The MHRA Yellow Card scheme exists for patients who experience side effects that feel significant or unexpected, and it is worth knowing about. Reporting there contributes to the ongoing post-market surveillance of medicines like Wegovy. If burping is accompanied by severe or persistent stomach pain that radiates to the back, that warrants urgent medical attention rather than self-management.
If you are considering starting treatment and want to understand how a prescriber weighs up the full side-effect picture alongside your personal circumstances, the treatment consultation process begins with a clinical review at no cost.
Sulphurous burping alone, even when persistent, is rarely a clinical concern. It sits alongside the other gastrointestinal effects that are characteristic of GLP-1 treatment, which is why the titration schedule starts conservatively and increases gradually.
There are situations where it is worth raising with a prescriber rather than waiting. If burping is accompanied by significant nausea that is preventing you from eating adequately, if it has not reduced at all after four to six weeks, or if it worsens again outside of a dose-increase window, those patterns deserve a conversation. If you are earlier in your research and want a clear explanation of whether semaglutide causes burping and why it happens, that question is covered in detail separately. Similarly, if you are also experiencing symptoms like changes in stool colour or consistency, that broader picture is worth discussing.
A prescriber can review whether the titration pace suits you, whether any other medicine you take is interacting with gastric motility, or whether the dose timing adjustment mentioned above is worth formalising. That is not a reason to stop treatment without advice, and it is not something to push through entirely alone either.
For a broader overview of what semaglutide involves, the Wegovy information page covers the full treatment picture in one place.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.